State of Tennessee Department Of Revenue Issues Solicitation Notice for Unclaimed Vehicle Portal

Nashville, Tenn., Sept. 3 -- The State of Tennessee Department Of Revenue (34717-01017) for Unclaimed Vehicle Portal. Description: The State is looking for a single, experienced vendor to implement ... Read More

Holista Executes Binding JV for Collie Collagen Facility

Indonesia, May 5 -- Holista Colltech Limited (ASX: HCT) (Holista or the Company) is pleased to announce that it has entered into a binding Joint Venture Agreement with Swang Chai Chuan Limited (HKEX: ... Read More

Two Sumatran tiger cubs born in Lampung conservation park

Indonesia, May 5 -- A conservation facility in Indonesia's Lampung Province has recorded a milestone in wildlife preservation with the birth of two Sumatran tiger cubs from parents that survived poach... Read More

KPK says Whoosh probe still in preliminary stage

Jakarta, May 5 -- Indonesia's anti-graft agency said its probe into alleged corruption in the Jakarta-Bandung high-speed rail project remains at the preliminary inquiry stage, citing case management p... Read More

Professional Investment Advisory Services' Management Successfully Completes Change in Ownership

Indonesia, May 5 -- Professional Investment Advisory Services Pte Ltd ("PIAS") today announced that its management has completed the acquisition of PIAS from Singapore Life Limited ("Singlife"), throu... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, May 5 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, May 5 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, May 5 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) ... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»